4//SEC Filing
VANCE DOLLY 4
Accession 0001140361-22-033613
CIK 0001034842other
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 4:15 PM ET
Size
5.4 KB
Accession
0001140361-22-033613
Insider Transaction Report
Form 4
VANCE DOLLY
SVP, Gen. Counsel, Corp. Sec.
Transactions
- Award
Employee Stock Option (right to buy)
2022-09-14+81,250→ 81,250 totalExercise: $2.00Exp: 2029-01-23→ Common Stock (81,250 underlying)
Footnotes (2)
- [F1]The reporting person was granted an option with a performance-based condition with respect to 81,250 shares of common stock on January 23, 2019. Thus, the exercise price of this option is $2.00 (the closing price of the issuer's common stock on Nasdaq the date of grant). In light of the performance-based vesting condition of this grant, the grant was not reportable under Section 16 until the performance metric was satisfied. On September 14, 2022, it was determined that the performance metric had been met.
- [F2]The option was fully vested on September 14, 2022, the date the determination was made that the performance metric had been met.
Documents
Issuer
RIGEL PHARMACEUTICALS INC
CIK 0001034842
Entity typeother
Related Parties
1- filerCIK 0001237676
Filing Metadata
- Form type
- 4
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 4:15 PM ET
- Size
- 5.4 KB